Suchergebnisse - "Xing, Puyuan"

PubPharm (179)

1

Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing

enthalten in: Expert review of anticancer therapy | 2024

von Xu, Z. | Li, Y. | Wang, L. | +4

2

Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Wang, S. | Hao, X. | Dai, L. | +12

3

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

4

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology immunotherapy | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

5

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

enthalten in: Journal of biomedical science | 2024

von Sun, D. | Qian, H. | Li, J. | +1

6

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy

enthalten in: Journal of biomedical science | 2024

von Sun, D. | Qian, H. | Li, J. | +1

7

Low TP53 variant allele frequency as a biomarker for anti-programmed death (ligand) 1 monotherapy in lung adenocarcinoma

enthalten in: Cancer | 2023

von Wang, S. | Xie, T. | Li, Y. | +7

8

Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer : a Chinese, multicenter, real-world cohort study

enthalten in: Translational lung cancer research | 2023

von Zhang, D. | Liu, X. | Shen, F. | +37

9

Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer : a network meta-analysis

enthalten in: Chinese medical journal | 2023

von Zhu, Y. | Liu, C. | Xu, Z. | +5

10

Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities

enthalten in: Pharmacological research | 2023

von Yang, L. | Zhang, Z. | Dong, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]